
Published
22 September 2011 | By Kinapse
Life sciences R&D organisations have made advancements in managing the performance of their development projects and portfolios, yet prioritisation, resource and budget allocation, and the tracking of value creation remain hard to achieve. This article argues that life sciences R&D organisations should adopt EVM, describes the benefits of applying EVM at the project level, and explores the potential for additional benefits at the portfolio level.
As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details
By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory
Fields marked * are compulsory